Physician profile
Jillian Bott
NPI 1225791486
$762.39
in general payments reported to CMS, 2019-2025
17 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.39 · 2022: $450 · 2023: $97.24 · 2024: $41.29 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $154.68 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $85.31 | 2022 | |
| Novo Nordisk INC | $80.43 | 2022 | |
| Hologic Sales and Service, LLC | $57.74 | 2022-2024 | Aptima |
| Viiv Healthcare Company | $48.58 | 2022 | |
| Exeltis, USA INC. | $46.21 | 2025 | Slynd |
| Pfizer INC. | $43.76 | 2023 | |
| Merck Sharp & Dohme LLC | $36.16 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $33.14 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.01 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.23 | 2021 | |
| Lundbeck LLC | $23.50 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.24 | 2022 | |
| Coopersurgical, INC. | $21.44 | 2024 | Paragard T 380a |
| Daiichi Sankyo INC. | $20.00 | 2025 | Vanflyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.78 | 2025 | Myfembree |
| Lucid Diagnostics INC. | $17.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Bott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.